Quantum Pharmaceuticals is pleased to release Quantum Science Overview. The document conveys an overview Quantum’s drug discovery solutions and scientific results. The content of the report are summarized below:
I. A Novel Integrated Approach in Drug Discovery 1
II. QUANTUM free energy vs. statistical scoring functions
III. Inside Quantum Drug Discovery Studio: Molecular Modeling Concepts and Tools
IV. QDDS and Molecular Interactions in Aqueous Environments (Solvation Model).
V. Collective (non-additive) contributions to a protein-ligand complex binding free energy.
VI. Discovery of new classes of HIV integrase inhibitors.
VII. Biological Spectra Analysis: Linking Biological Activity Profiles to Molecular Toxicity.

Appendices
A. Structure of a Basic PBPK Model applied in q-ADME
B. Binding affinity calculation of known drugs tohuman serum albumin
C. Rediscovery of Blockbuster drugs with QUANTUM

Related posts:

1. HIV-1 integrase drug discovery collaboration
2. q-hERG: QUANTUM’s innovative approach to hERG binding calculations is finally released
3. From Biological Spectra (multiple protein binding data) to pharmacological profiling!
4. Quantum and Institute of Pulmonology entered COPD drug discovery collaboration.
5. QUANTUM and HSA binding calculations: the role of protein flexibility